# Ray Liu

> Ray Liu is the CEO and co-founder of Vena Vitals, an Irvine, California medtech startup building a soft, skin-like sticker that tracks blood pressure continuously, beat by beat, without cuffs or invasive arterial lines. A National Science Foundation fellow turned operator, Liu spent two decades inside GE Healthcare, Siemens, and Vizient, and racked up two health-tech exits before reuniting with a former Berkeley labmate, UC Irvine professor Michelle Khine, and PhD scientist Josh Kim to turn a material-science breakthrough into a clinical product. Backed by Y Combinator, MedTech Innovator, and EvoNexus, Vena Vitals has tested its sensor on 600-plus patients in operating rooms and is targeting FDA clearance in 2026.

- **Role:** CEO & Co-Founder at Vena Vitals
- **Organizations:** Vena Vitals, Vizient, Socialwellth, GE Healthcare, Siemens
- **Nationality:** American
- **Education:** BS, Electrical Engineering, University of Illinois, MS, Electrical/Biomedical Engineering, UC Berkeley, MBA, General Management, Harvard Business School
- **Known for:** Co-founded and leads Vena Vitals, developer of a non-invasive continuous blood pressure monitoring sticker, Two prior health-tech exits (to Cigna and Vizient), Tested the Vena Vitals sensor on 600+ patients in operating rooms nationwide, matching arterial-line accuracy

## Career timeline

- **2002** — National Science Foundation Fellow at the Berkeley Sensor and Actuator Center (BSAC), researching DNA hybridization sensing with field-effect transistors
- **2004-2010** — GE Healthcare - Global Product Surveillance Leader, then Senior Consultant in Siemens Management Consulting
- **2014-2018** — Head of Product and Business Development at Socialwellth (health-tech exit)
- **2018-2019** — Senior Director of Product Management and Strategy at Vizient, Inc.
- **2019** — Co-founded Vena Vitals with Michelle Khine and Josh Kim in Irvine, California; serves as CEO
- **2020** — Vena Vitals joins Y Combinator (Summer 2020 batch)
- **2026** — Targeting FDA clearance for hospital use of the continuous blood pressure sensor

## Achievements

- Co-founded and leads Vena Vitals, developer of a non-invasive continuous blood pressure monitoring sticker
- Two prior health-tech exits (to Cigna and Vizient)
- Tested the Vena Vitals sensor on 600+ patients in operating rooms nationwide, matching arterial-line accuracy
- Secured backing from Y Combinator, MedTech Innovator, and EvoNexus
- 15+ years of leadership across GE Healthcare, Siemens, and startups, with FDA medical-device approval experience
- Former National Science Foundation Fellow at UC Berkeley's BSAC

## Latest updates

- **2026-02** — UC Irvine features Vena Vitals as it targets FDA clearance in 2026; team grows to roughly 14 with sensor validated against arterial lines in 600+ patients.

## Links

- Website: https://venavitals.com
- LinkedIn: http://www.linkedin.com/in/rayliu
- YouTube: https://www.youtube.com/watch?v=9dHmsPkd9lU

---

Profile page: https://yespress.io/ray-liu
Published by YesPress — https://yespress.io
Last updated: 2026-06-21